中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

82 records (took 0.029 seconds)

    Lactams
    1.
    发明授权
    Lactams 有权
    里米尔斯

    公开(公告)号：US09586901B2

    公开(公告)日：2017-03-07

    申请号：US12087862

    申请日：2007-01-24

    Applicant: Naresh Kumar ,  George Iskander

    Inventor： Naresh Kumar ,  George Iskander

    IPC: C07D207/38 ,  C08F26/06 ,  A01N43/36 ,  C07D207/273 ,  C07D207/27 ,  C07D207/36 ,  C07D207/44

    CPC classification number: C07D207/44 ,  A01N43/36 ,  C07D207/27 ,  C07D207/273 ,  C07D207/36 ,  C07D207/38 ,  C08F26/06 ,  A01N25/10

    Abstract: Lactams of formulae (I) and (II) and their use in the treatment of microbial infections and microbial contamination of surfaces, particularly infections and surface contaminations characterized by biofilm formation. Compounds of formula (I) and (II) substituted with acrylate or methacrylate groups and their attachment to surfaces or polymers to inhibit microbial contamination are also provided.

    Abstract translation: 式（I）和（II）的内酰胺及其用于治疗表面微生物感染和微生物污染，特别是以生物膜形成为特征的感染和表面污染物。 还提供了用丙烯酸酯或甲基丙烯酸酯基团取代的式（I）和（II）化合物及其与表面或聚合物的连接以抑制微生物污染。

    Novel Lactams
    2.
    发明申请
    Novel Lactams 有权
    小说里加斯

    公开(公告)号：US20130190377A1

    公开(公告)日：2013-07-25

    申请号：US12087862

    申请日：2007-01-24

    Applicant: Naresh Kumar ,  George Iskander

    Inventor： Naresh Kumar ,  George Iskander

    IPC: C07D207/38 ,  C08F26/06 ,  A01N43/36 ,  C07D207/273 ,  C07D207/27

    CPC classification number: C07D207/44 ,  A01N43/36 ,  C07D207/27 ,  C07D207/273 ,  C07D207/36 ,  C07D207/38 ,  C08F26/06 ,  A01N25/10

    Abstract: The present invention relates to novel lactams of formulae (I) and (II). The present invention further relates to the use of these compounds in the treatment of microbial infections and microbial contamination of surfaces, particularly infections and surface contaminations characterised by biofilm formation. Further provided are compounds of formula (I) and (II) substituted with acrylate or methacrylate groups and their attachment to surfaces or polymers to inhibit microbial contamination.

    Abstract translation: 本发明涉及式（I）和（II）的新型内酰胺。 本发明还涉及这些化合物在治疗表面的微生物感染和微生物污染的用途，特别是以生物膜形成为特征的感染和表面污染物。 还提供了用丙烯酸酯或甲基丙烯酸酯基团取代的式（I）和（II）化合物及其与表面或聚合物的连接以抑制微生物污染。

    SYSTEM AND METHOD FOR BILLING SYSTEM INTERFACE FAILOVER RESOLUTION
    3.
    发明申请
    SYSTEM AND METHOD FOR BILLING SYSTEM INTERFACE FAILOVER RESOLUTION 有权
    用于计费系统界面故障分解的系统和方法

    公开(公告)号：US20110283003A1

    公开(公告)日：2011-11-17

    申请号：US13189524

    申请日：2011-07-24

    Applicant: Naresh Kumar ,  Robert Perry

    Inventor： Naresh Kumar ,  Robert Perry

    IPC: G06F15/16

    CPC classification number: H04L12/14 ,  G06F11/2033 ,  G06F11/2038 ,  G06F11/2041 ,  H04L12/1403 ,  H04L69/40 ,  H04M15/70 ,  H04M15/74 ,  H04M2215/70 ,  H04M2215/709

    Abstract: A determination is made whether a first application server of a group of N application servers, N being at least two, is a coordinator of the group. Responsive to determining that the first application server is the coordinator of the group, a connection to a billing system is established, via a terminal server, by the first application server. A determination is made whether a second application server of the group of N application servers is the coordinator of the group. Responsive to determining that the second application server is not the coordinator of the group, a periodic check is made whether the second application server of the group of N application servers is the coordinator of the group. The second application server may later be determined to be the coordinator of the group, when the first server experiences difficulty. Once it is determined that the second application server now is the coordinator of the group, a connection is established to the billing system, via the terminal server, by the second application server.

    Abstract translation: 确定一组N个应用服务器的第一应用服务器是否为该组的协调器，N至少为两个。 响应于确定第一应用服务器是该组的协调器，通过终端服务器由第一应用服务器建立与计费系统的连接。 确定N个应用服务器组的第二应用服务器是否是该组的协调器。 响应于确定第二应用服务器不是组的协调器，定期检查N个应用服务器组中的第二应用服务器是否是该组的协调器。 当第一服务器遇到困难时，可以将第二应用服务器确定为该组的协调器。 一旦确定第二应用服务器现在是组的协调器，则通过第二应用服务器经由终端服务器向计费系统建立连接。

    Dynamic conditional security policy extensions
    4.
    发明授权
    Dynamic conditional security policy extensions 有权
    动态条件安全策略扩展

    公开(公告)号：US07945960B2

    公开(公告)日：2011-05-17

    申请号：US11296086

    申请日：2005-12-06

    Applicant: Raymond K. Ng ,  Ganesh Kirti ,  Thomas Keefe ,  Naresh Kumar

    Inventor： Raymond K. Ng ,  Ganesh Kirti ,  Thomas Keefe ,  Naresh Kumar

    IPC: H04L9/32

    CPC classification number: H04L63/08

    Abstract: Systems, methods, and machine-readable media are disclosed for providing conditional grants of permission in an externally configured security policy. In one embodiment, a method is provided which comprises reading a condition clause from a grant statement defined in the security policy. The grant statement can cause the granting of permission for a user to access a requested resource. One or more constraints on the grant statement can be determined based on the condition clause. Permission can be granted to access the requested resource based on the one or more constraints.

    Abstract translation: 公开了用于在外部配置的安全策略中提供有限许可的系统，方法和机器可读介质。 在一个实施例中，提供了一种方法，其包括从安全策略中定义的授权语句读取条件子句。 授权语句可能导致授予用户访问所请求资源的权限。 授权语句的一个或多个约束可以基于条件子句来确定。 可以授予权限以基于一个或多个约束来访问所请求的资源。

    Isoflavonoid dimers
    5.
    发明授权
    Isoflavonoid dimers 失效
    异黄酮二聚体

    公开(公告)号：US07700644B2

    公开(公告)日：2010-04-20

    申请号：US11909538

    申请日：2006-03-24

    Applicant: Andrew Heaton ,  Naresh Kumar

    Inventor： Andrew Heaton ,  Naresh Kumar

    IPC: A61K31/352 ,  C07D493/04

    CPC classification number: C07D493/04

    Abstract: Novel compounds based on phenyl-substituted naphtho[1,2-g]chrysene compounds (A) are described. The compounds are obtainable by dimerisation of 3-phenylchroman (isoflavonoid) ring systems (B). Methods of synthesis of the novel dimeric compounds, compositions containing same and use of the dimers as therapeutic agents are also described.

    Abstract translation: 描述了基于苯基取代萘并[1,2-g]化合物（A）的新型化合物。 该化合物可通过3-苯基苯并二氢吡喃（异黄酮）环体系（B）的二聚得到。 还描述了新型二聚化合物的合成方法，含有它们的组合物和二聚体作为治疗剂的用途。

    Dynamic constraints for query operations
    8.
    发明申请
    Dynamic constraints for query operations 有权
    查询操作的动态约束

    公开(公告)号：US20070130616A1

    公开(公告)日：2007-06-07

    申请号：US11296027

    申请日：2005-12-06

    Applicant: Raymond Ng ,  Ganesh Kirti ,  Thomas Keefe ,  Naresh Kumar

    Inventor： Raymond Ng ,  Ganesh Kirti ,  Thomas Keefe ,  Naresh Kumar

    IPC: H04L9/32

    CPC classification number: G06F21/6227 ,  G06F2221/2105 ,  G06F2221/2149 ,  H04L63/168

    Abstract: Systems, methods, and machine-readable media are disclosed for providing dynamic and/or conditional constraints on queries based on an external security policy. In one embodiment, a method is provided which comprises receiving from a user a request to access a resource. A condition clause can be read from a grant statement defined in the security policy. The grant statement can define permission for the user to access the requested resource. In some cases, the grant statement can comprise a Java Authentication and Authorization Service (JAAS) grant statement. A query associated with the requested access can be modified based on the permission granted to the user. The modified query can then be made to perform the requested access.

    Abstract translation: 公开了系统，方法和机器可读介质，用于基于外部安全策略来提供关于查询的动态和/或条件约束。 在一个实施例中，提供了一种方法，其包括从用户接收访问资源的请求。 可以从安全策略中定义的授权语句读取条件子句。 授权语句可以定义用户访问所请求资源的权限。 在某些情况下，授权语句可以包含Java认证和授权服务（JAAS）授权语句。 可以基于授予用户的权限来修改与请求的访问相关联的查询。 然后可以使修改的查询执行请求的访问。

    Production of furanones
    9.
    发明申请
    Production of furanones 失效
    生产呋喃酮

    公开(公告)号：US20070032666A1

    公开(公告)日：2007-02-08

    申请号：US11414552

    申请日：2006-05-01

    Applicant: Roger Read ,  Naresh Kumar

    Inventor： Roger Read ,  Naresh Kumar

    IPC: C07D305/12

    CPC classification number: C08F20/00 ,  A01N43/08 ,  C07D307/58 ,  C08F24/00

    Abstract: The present invention relates to the side chain functionalization of fimbrolides (halogenated 3-alkyl-5-methylene-2(5H)-furanones) and their synthetic analogues, that yields fimbrolides substituted with a halogen, an oxygen or a nitrogen functionality in the alkyl chain, especially fimbrolide alcohols, caboxylate and sulfinate and sulfonate esters, ethers, aldehydes, ketones, acids, amides, nitro derivatives, hydrophobic, hydrophilic and fluorophilic alkyl derivatives and polymers.

    Abstract translation: 本发明涉及福滨洛尔（卤代3-烷基-5-亚甲基-2（5H） - 呋喃酮）及其合成类似物的侧链官能化，其产生在烷基中被卤素，氧或氮官能团取代的菲莫拉林 链，特别是曲芬洛尔醇，卡波西铵和亚磺酸盐和磺酸酯，醚，醛，酮，酸，酰胺，硝基衍生物，疏水性，亲水和氟烷基衍生物和聚合物。

    Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    10.
    发明申请
    Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists 审中-公开
    取代的氮杂双环己烷衍生物作为毒蕈碱受体拮抗剂

    公开(公告)号：US20070010568A1

    公开(公告)日：2007-01-11

    申请号：US10544520

    申请日：2003-02-07

    Applicant: Anita Mehta ,  Bruhaspathy Miriyala ,  Naresh Kumar ,  Jang Gupta

    Inventor： Anita Mehta ,  Bruhaspathy Miriyala ,  Naresh Kumar ,  Jang Gupta

    IPC: A61K31/403 ,  C07D209/02

    CPC classification number: C07D471/08

    Abstract: This invention relates to derivatives of substituted azabicyclo hexanes. The compound of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.

    Abstract translation: 本发明涉及取代的氮杂双环己烷的衍生物。 本发明化合物可用作毒蕈碱受体拮抗剂，可用于治疗通过毒蕈碱受体介导的呼吸道，尿路和胃肠道系统的各种疾病。 本发明还涉及制备本发明化合物的方法，含有本发明化合物的药物组合物以及通过毒蕈碱受体介导的疾病的治疗方法。

Patent Agency Ranking